PALI

PALISADE BIO INC

PALI·696389402·US·Common Stock·Healthcare - Biotechnology-13D/G

PALI (PALISADE BIO INC) is held by 50 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($18.8M), AMERIPRISE FINANCIAL INC ($15.2M), RA CAPITAL MANAGEMENT, L.P. ($12.5M). Net institutional sentiment: Mixed.

50
Holders
Avg rating(11 Elite)
$128.4M
Total Value
57% (59)
Fund Consensus
31 buying - 23 selling
PALISmart Money Verdict
View all
Held by 50 funds
11 elite
Who's Trading
ActivistSMSoleus Capital Master Fund, L.P.5.4%May 27, 2026
ActivistAmeriprise Financial, Inc.Ameriprise Financial, Inc.5.3%May 15, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.0.2%May 15, 2026
ActivistPAPerceptive Advisors LLC7.9%May 15, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.9.9%May 15, 2026
ActivistCOCommodore Capital LP7.2%May 15, 2026
ActivistSMSquadron Master Fund LP3.0%Feb 17, 2026
ActivistDTDeep Track Capital, LP0.0%Feb 13, 2026
InsiderWAWilliams Donald AllenBuy $8KJan 16, 2026
InsiderWAWilliams Donald AllenBuy $9KJan 9, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
10.7M(+1.4%)$18.8M0.0%-16.62%
29
Increased
8.7M(+26.1%)$15.2M0.0%-11.77%
35
Unchanged
7.1M$12.5M0.1%-16.95%
0
Increased
5.8M(+13.6%)$10.1M0.0%-14.03%
31
Increased
5.4M(+863.8%)$9.4M0.0%+11.40%
45
Increased
4.6M(+9.9%)$8M0.0%-14.68%
30
Unchanged
4.5M$7.9M0.0%-16.95%
0
Increased
3.3M(+905.3%)$5.7M0.0%+11.58%
44
New
3.1M$5.5M0.0%+15.98%
37
New
2.9M$5.1M0.0%+15.98%
37
New
2.8M$4.8M0.0%+15.98%
37
Increased
2.1M(+614.3%)$3.7M0.0%+9.88%
43
Decreased
1.9M(-0.2%)$3.3M0.0%-16.95%
0
Decreased
1.5M(-1.2%)$2.7M0.0%-16.18%
0
Decreased
1.5M(-39.0%)$2.5M0.0%-16.95%
0
New
1.4M$2.5M0.0%+15.98%
36
Increased
1.2M(+371.0%)$2M0.0%+8.39%
42
New
662,900$1.2M0.0%+15.98%
35
New
659,289$1.2M0.0%+15.98%
35
Decreased
636,197(-1.2%)$1.1M0.0%-16.95%
0

Showing 1-20 of 59

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used